Development of New Technologies and Applications through Basic and Applied Research
First written in FY2016. 26 of 35 entries say "Restated". Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As the Company enters this landmark year marking its 100th anniversary, it is further strengthening its R&D structure to establish a foundation for sustainable growth with the “next 100 years” in view. Research and development is currently being led by the Central Research Institute, with 30 R&D staff, representing 12.6% of all employees. Total R&D expenses incurred during the fiscal year were ¥322 million.」
With the 100th anniversary and the next 100 years in view, the Company strengthened its R&D structure. It had 30 R&D staff, representing 12.6% of all employees, and recorded R&D expenses of ¥322 million. Specific initiatives included environmentally considerate manufacturing technology, manufacturing processes using digital transformation, basic materials research and new application development. - FY2026-H1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the interim consolidated accounting period was ¥159 million. There were no material changes in the status of the Group’s research and development activities during the interim consolidated accounting period.」
The Company recorded R&D expenses of ¥159 million for the interim consolidated accounting period and stated that there were no material changes in the status of research and development activities. - FY2025AdvancedAnnual report
「The Company will celebrate its 100th anniversary in 2026. To address the issues that must be tackled in preparation for this milestone and establish new technologies that will form the core of future business growth, the Company is strengthening a broad range of basic and applied research. Research and development is currently being led by the Central Research Institute, with 30 R&D staff, representing 12.2% of all employees. Total R&D expenses incurred during the fiscal year were ¥344 million.」
The Company had 30 R&D staff, representing 12.2% of all employees, and recorded R&D expenses of ¥344 million. The scope of research included environmentally considerate manufacturing technology, manufacturing processes using digital transformation, particle-surface control, inorganic-material synthesis and new application development. - FY2025-H1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the interim consolidated accounting period was ¥174 million. There were no material changes in the status of the Group’s research and development activities during the interim consolidated accounting period.」
The Company recorded R&D expenses of ¥174 million for the interim consolidated accounting period and stated that there were no material changes in the status of research and development activities. - FY2024AdvancedAnnual report
「The Company will celebrate its 100th anniversary in 2026. While strongly advancing efforts to resolve the issues that must be addressed in preparation for this milestone, the Company is actively pursuing a broad range of basic and applied research to establish new technologies that will form the core of future business growth. The Group’s research and development is currently being led by the Company’s Central Research Institute. Total R&D staff comprises 30 people, representing 11.0% of the Group’s total employees. Total R&D expenses incurred during the fiscal year were ¥319 million.」
The Company had 30 R&D staff, representing 11.0% of total employees, and recorded R&D expenses of ¥319 million. Specific research results included environmentally considerate manufacturing technology, particle-surface modification, inorganic-material synthesis, application development in the medical, housing materials, automotive materials and synthetic resin sectors, and expanded overseas applications. - FY2024-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the nine months ended the third quarter was ¥236 million. There were no material changes in the status of the Group’s research and development activities during the nine months ended the third quarter.」
R&D expenses for the nine months ended the third quarter of the 76th fiscal year were ¥236 million, and it is stated that there were no material changes in the status of research and development activities. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter was ¥155 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
R&D expenses for the six months ended the second quarter of the 76th fiscal year were ¥155 million, and it is stated that there were no material changes in the status of research and development activities. - FY2024-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥73 million. There were no material changes in the status of the Group’s research and development activities during the three months ended the first quarter.」
R&D expenses for the first quarter of the 76th fiscal year were ¥73 million, and it is stated that there were no material changes in the status of research and development activities. - FY2023AdvancedAnnual report
「③ To continuously take on new challenges without fear of failure, we will make extensive use of project teams centered on younger employees to build their experience and improve our production and R&D structures.」
The Company made concrete its use of project teams centered on younger employees as a means of improving its R&D and production structures. The Company had 29 R&D staff, representing 10.8% of total employees, and R&D expenses were ¥284 million. Results included the establishment of manufacturing technology, overseas expansion of new grades, product development for high-performance resins, and expanded applications in automotive materials. - FY2023-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter was ¥141 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
R&D expenses for the six months ended the second quarter of the 75th fiscal year were ¥141 million, and it is stated that there were no material changes in the status of research and development activities. - FY2023-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥70 million. There were no material changes in the status of the Group’s research and development activities during the three months ended the first quarter.」
R&D expenses for the first quarter of the 75th fiscal year were ¥70 million, and it is stated that there were no material changes in the status of research and development activities. - FY2022AdvancedAnnual report
「The Group conducts R&D activities to enhance the functionality and performance of products for a wide range of applications sought by users in Japan and overseas, drawing on the characteristics of various inorganic powders, primarily calcium carbonate. Accordingly, the Group is actively pursuing a broad range of basic and applied research while strongly promoting the development of new products and establishing new technologies that will form the core of future business growth. The Group’s research and development is currently being led by the Company’s Central Research Institute. The R&D staff comprises 28 people, representing 10.5% of the Group’s total employees. Total R&D expenses incurred during the fiscal year were ¥323 million. (1) Manufacturing technology for calcium carbonate has been established to achieve a higher and consistent level of quality at all manufacturing sites in Japan and overseas. The Group has also launched a project and begun examining initiatives toward carbon neutrality.」
The Company had 28 R&D staff, representing 10.5% of total employees, and recorded R&D expenses of ¥323 million. Specific results included the establishment of manufacturing technology delivering consistent quality in Japan and overseas, adoption and supply-system development in the food, housing materials, automotive materials and synthetic resin sectors, and other achievements. - FY2022-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the nine months ended the third quarter was ¥252 million. There were no material changes in the status of the Group’s research and development activities during the nine months ended the third quarter.」
R&D expenses for the nine months ended the third quarter of the 74th fiscal year were ¥252 million. It has been reconfirmed that there were no material changes in the status of research and development activities. - FY2022-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter was ¥148 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
R&D expenses for the six months ended the second quarter of the 74th fiscal year were ¥148 million, and it is stated that there were no material changes in the status of research and development activities. - FY2022-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥70 million. There were no material changes in the status of the Group’s research and development activities during the three months ended the first quarter.」
The Company recorded R&D expenses of ¥70 million and reconfirmed that there were no material changes in the status of research and development activities. - FY2021AdvancedAnnual report
「③ We will improve our R&D structure by using a “project-team mindset” that involves continuously taking on new challenges without fear of failure. The Group’s research and development is currently being led by the Company’s Central Research Institute. The R&D staff comprises 27 people, representing 10.4% of the Group’s total employees. Total R&D expenses incurred during the fiscal year were ¥272 million, excluding consumption taxes and other taxes.」
The Company set out a policy of incorporating a project-team mindset into research and development, and recorded 27 R&D staff, representing 10.4% of total employees, and R&D expenses of ¥272 million. Results also included manufacturing technology that delivers consistent quality in Japan and overseas, adoption for new applications, and results in construction and automotive materials. - FY2021-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the nine months ended the third quarter was ¥202 million. There were no material changes in the status of the Group’s research and development activities during the nine months ended the third quarter.」
R&D expenses for the nine months ended the third quarter of the 73rd fiscal year were ¥202 million. It is stated that there were no material changes in the status of research and development activities. - FY2021-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter was ¥132 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
R&D expenses for the six months ended the second quarter of the 73rd fiscal year were ¥132 million, and it is stated that there were no material changes in the status of research and development activities. - FY2021-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥66 million. There were no material changes in the status of the Group’s research and development activities during the three months ended the first quarter.」
R&D expenses for the first quarter of the 73rd fiscal year were ¥66 million, and it has been reconfirmed that there were no material changes in the status of research and development activities. - FY2020AdvancedAnnual report
「The Group’s research and development is currently being led by the Company’s Central Research Institute. The R&D staff comprises 24 people, representing 9.2% of the Group’s total employees. Total R&D expenses incurred during the fiscal year were ¥297 million, excluding consumption taxes and other taxes. The main R&D activities and results during the fiscal year were as follows:」
The Company had 24 R&D staff, representing 9.2% of total employees, and recorded R&D expenses of ¥297 million. Results included the establishment of new technologies in the food sector, expanded applications in construction and automotive materials, and improved functionality in the synthetic resin sector. - FY2020-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the nine months ended the third quarter was ¥233 million. There were no material changes in the status of the Group’s research and development activities during the nine months ended the third quarter.」
R&D expenses for the nine months ended the third quarter of the 72nd fiscal year were ¥233 million, and it has been reconfirmed that there were no material changes in the status of research and development activities. - FY2020-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter was ¥129 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
The Group recognized R&D expenses of ¥129 million and reaffirmed that there were no material changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「The Group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥64 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
The Group recognized R&D expenses of ¥64 million and reaffirmed that there were no material changes in the status of its R&D activities. - FY2019RestatedAnnual report
「To meet the increasingly strong demand for higher functionality and performance in products and for differentiation in users' final products, the Group is vigorously developing new products. From a long-term perspective aimed at future business development, it is also actively pursuing a broad range of initiatives, from basic research into various inorganic powders, centered on calcium carbonate, to applied research to establish new technologies that will form the core of business advancement and expand into new applications.」
The Group continues its basic research, establishment of new technologies, development of new products, and expansion into new applications. R&D staff total 25, representing 9.6% of total employees, and R&D expenses were ¥264 million. The Group reports results in such fields as synthetic resins, construction materials, automotive materials, and food. - FY2019-Q3RestatedAnnual report
「The Group's total R&D expenses for the third quarter of the current consolidated cumulative period were ¥196 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
Cumulative R&D expenses for the third quarter were ¥196 million, and the Group reaffirmed that there were no material changes in the status of its R&D activities. - FY2019-Q2RestatedAnnual report
「The Group's total R&D expenses for the second quarter of the current consolidated cumulative period were ¥129 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
The Group recognized R&D expenses of ¥129 million and reaffirmed that there were no material changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「The Group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥60 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
The Group recognized R&D expenses of ¥60 million and reaffirmed that there were no material changes in the status of its R&D activities. - FY2018AdvancedAnnual report
「To meet the increasingly strong demand for higher functionality and performance in products and for differentiation in users' final products, the Group is vigorously developing new products. From a long-term perspective aimed at future business development, it is also actively pursuing a broad range of initiatives, from basic research into various inorganic powders, centered on calcium carbonate, to applied research to establish new technologies that will form the core of business advancement and expand into new applications.」
The Group reports 27 R&D staff, representing 10.4% of total employees, and R&D expenses of ¥326 million. It identifies product development in the construction materials field, expansion of applications for existing products, and research achievements in the food and agriculture fields as its main results. - FY2018-Q3RestatedAnnual report
「The Group's total R&D expenses for the third quarter of the current consolidated cumulative period were ¥210 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
R&D expenses for the third quarter of the current consolidated cumulative period were ¥210 million, and the Group reaffirmed that there were no material changes in the status of its R&D activities. - FY2018-Q2RestatedAnnual report
「The Group's total R&D expenses for the second quarter of the current consolidated cumulative period were ¥142 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
Cumulative R&D expenses were ¥142 million. The Group reaffirmed that there were no material changes in the status of its R&D activities. - FY2018-Q1RestatedAnnual report
「The Group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥72 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
R&D expenses were ¥72 million. The Group reaffirmed that there were no material changes in the status of its R&D activities. - FY2017-Q3RestatedAnnual report
「The Group's total R&D expenses for the third quarter of the current consolidated cumulative period were ¥231 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
R&D expenses for the third quarter of the current consolidated cumulative period were ¥231 million, and the Group states that there were no material changes in the status of its R&D activities. - FY2017-Q2RestatedAnnual report
「The Group's total R&D expenses for the second quarter of the current consolidated cumulative period were ¥152 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
R&D expenses for the second quarter of the current consolidated cumulative period were ¥152 million, and the Group states that there were no material changes in the status of its R&D activities. - FY2017-Q1RestatedAnnual report
「The Group's total R&D expenses for the first quarter of the current consolidated cumulative period were ¥74 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
Quarterly R&D expenses were ¥74 million, and the Group states that there were no material changes in the status of its R&D activities. - FY2016First statedAnnual report
「In order to maintain our fundamental capabilities as an intermediate materials manufacturer, we will earnestly pursue basic research and develop it into a broad range of applied research through our rich creativity.」
The Group positions the progression from basic research and applied research through the establishment of new technologies and expansion into new applications as a means of business development. R&D staff total 34, representing 12.7% of total employees, and R&D expenses were ¥299 million.